Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln
24/04/2026 02:24
April 24 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd 002393.SZ: TIANJIN LISHENG PHARMACEUTICAL QTRLY OPERATING INCOME RMB 332.28 MILLION QTRLY NET PROFIT ATTRIBUTABLE TO OWNERS FOR TIANJIN LISHENG PHARMACEUTICAL RMB 51.88 MILLION Further company coverage: 002393.SZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsBrief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To RMB70 Million Structured Deposit With Industrial Bank
Brief: Tianjin Development Proposes Final Dividend Of Hk8.82 Cents Per Share
Brief: Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln